Sanctuary Advisors, LLC Collegium Pharmaceutical, Inc Transaction History
Sanctuary Advisors, LLC
- $15.8 Trillion
- Q4 2024
A detailed history of Sanctuary Advisors, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Sanctuary Advisors, LLC holds 18,928 shares of COLL stock, worth $585,443. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,928
Previous 17,976
5.3%
Holding current value
$585,443
Previous $539 Million
14.26%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding COLL
# of Institutions
248Shares Held
37.6MCall Options Held
100KPut Options Held
10K-
Black Rock Inc. New York, NY5.79MShares$179 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$81.5 Million1.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$72.6 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$66.3 Million0.15% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$51.2 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.06B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...